12:00 AM
Oct 10, 2013
 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information
Drug platforms
Treating inflammation using mesenchymal stem cells (MSCs) overexpressing P selectin glycoprotein ligand-1 (PSGL-1; CD162; SELPLG), Sialyl-LewisX...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >